title: Anti-signal recognition particle-positive juvenile polymyositis successfully treated with rituximab.
authors: Nadia J C
authors: NJ
authors: Luca
authors: Adelle
authors: A
authors: Atkinson
authors: Cynthia
authors: C
authors: Hawkins
authors: Brian M
authors: BM
authors: Feldman
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001323:Autoantibodies / Q000097:blood*; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use; D000077339:Leflunomide; D018482:Muscle, Skeletal / Q000187:drug effects / Q000201:enzymology; D017285:Polymyositis / Q000188:drug therapy* / Q000473:pathology; D000069283:Rituximab; D018271:Signal Recognition Particle / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D018271:Signal Recognition Particle; D000069283:Rituximab; D000077339:Leflunomide; D001379:Azathioprine